Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Helicobacter pyloriinfection and its association with anemia among adult dyspeptic patients attending Butajira Hospital, Ethiopia

BMC Infectious Diseases201414:656

https://doi.org/10.1186/s12879-014-0656-3

Received: 18 August 2014

Accepted: 24 November 2014

Published: 9 December 2014

Abstract

Background

Helicobacter pylori infection is associated with anemia. Understanding the magnitude of H.pylori infection and its association with anemia is important in the management of anemic patients. The aim of this study was to assess the association between H.pylori infection and anemia among dyspeptic patients.

Methods

A cross-sectional study was conducted in Butajira Hospital, Southern Ethiopia among 401 systematically dyspeptic patients. A structured questionnaire was used to collected data about the patient characteristics. Blood samples were analyzed for red blood cell parameters. Stool samples were assessed for the presence of H.pylori antigens and the presence of intestinal helminthes. Data were summarized in frequencies (%) and mean (SD) as appropriate. Chi-square test, logistic regression and independent t-tests were used in the analysis as needed. In all cases P-value <0.05 was considered as statistically significant.

Results

The overall prevalence of H. pylori infection was 52.4% and it was significantly associated with age, presence of intestinal parasites, smoking habit, alcohol drinking habit and body mass index. The prevalence of anemia among H.pylori infected patients (30.9%) was significantly (P < 0.001) higher than uninfected patients (22.5%). The mean (SD) values of HGB, MCV, MCH, MCHC, HCT and RBC count was significantly different between H.pylori infected and uninfected patients.

Conclusion

This study showed high prevalence of H.pylori infection among dyspeptic patients and this was associated with age and some behavioral characteristics of the patients. H.pylori infected patients showed high rate of anemia prevalence as compared to their H.pylori unifected counter parts. From this study it can be recommended that intervention activities related to the behavioral characteristics and prevention of intestinal parasitic infections should be in place. The cross sectional nature of the study has a limitation to show cause and effect associations and hence association between H.pylori infections with anemia need to be investigated in cohort type studies.

Keywords

Anemia Butajira Dyspepeptic H.pylori

Background

Helicobacter pylori infection has been recognized as one of the most common chronic bacterial infections in humans and infecting more than half of the population of the world. The overall prevalence is high in developing countries [1]. H. pylori infection is a worldwide problem but the prevalence varies from country to country [1],[2]. H. pylori infection is acquired in early childhood and becomes a chronic infection if left untreated [3]. The majority of infected people remain asymptomatic, and only small portions develop illness, usually in adulthood [4]. H. pylori cause upper gastrointestinal disease such as gastritis, peptic ulcer disease and also increase the risk of gastric cancer [5],[6]. Male gender, increasing age, shorter height, tobacco use, lower socioeconomic status, obesity, and lower educational status of the parents in studies conducted among children are proposed risk factors for infection [7].

Several studies suggested an association between H. pylori infection with iron deficiency and anemia [8],[9]. H. pylori infection and extra gastric manifestations, pernicious anemia (10) and idiopathic thrombocytopenic purpura have been reported [10],[11]. Active H. pylori infection was independently associated with iron deficiency and iron-deficiency anemia [12],[13] and presence of H. pylori infection is associated with a poorer response to oral iron therapy [14]. It has been suggested that eradication of H. pylori may result in improvement of anemia even without iron supplementation [14],[15].

It is hypothesized that H. pylori-associated with anemia is caused by both compromised absorption of bio-available iron in the context of hypochlorhydria [16], and the competing iron demands of H. pylori and the host [17],[18]. Most dietary iron is in the non-hemic ferric form, and an acidic intra-gastric pH is needed to reduce it to the ferrous form for absorption. This reaction is promoted by gastric acidity and ascorbic acid, which is thus considered the most potent regulator of iron absorption [19]. H. pylori a major cause of chronic superficial gastritis leading to atrophy of gastric glands and leading to decreased gastric acid secretion [20]. H. pylori need iron to thrive and it possesses a 19-kDa iron-binding protein resembling ferritin, that may play a role in storage of excessive iron by the bacteria [21]. Moreover, since these bacteria have a high turnover rate, a large amount of iron may be lost in stools in the form of dead bacteria [22]. H. pylori has been found more frequently in dyspeptic patients [23]. The aim of the current study was to investigate the relation between H. pylori infection and anemia among dyspeptic patients attending medical care at Butajira Hospital.

Methods

Study area

The study was conducted at Butajira hospital which is found in Butajira town, Gurage Zone, Southern Nations Nationalities, and People’s Region (SNNPR) located 135 km from the capital-city, Addis Ababa. The town lies on the average at 2,100 m above the sea level. Butajira hospital is a zonal hospital with 110 beds that gives health service for peoples living in Butajira and the surrounding rural kebeles. The hospital report shows that it gives health service for an average of about 250 patients per day at the outpatient department. The hospital catchment area population is estimated around 1.3 million.

Study design and period

A cross-sectional prospective study was conducted from April to Jun 2013.

Sample size and sampling technique

The sample size was determined by using single population proportion formula taking 53% prevalence of H. pylori infection among dyspeptic patients [24] and a marginal error of 5%. Accordingly the sample size was determined 382 but we also considered a 5% non-response rate so that the final sample size was 401.

Study subjects were included using systematic random sampling technique. In Butajira hospital an average of 18 dyspeptic patients attend the outpatient clinic each day. The total expected dyspeptic patients during the study period were estimated 792. When the total population was divided by the sample size, the sample interval was found 2 and every two dyspeptic patient were selected until a total of 401 samples obtained.

All adult (age ≥18 years) patients presented with dyspepsia complaint were included in the study. Among those patients who were voluntary to participate in the study, those who had any surgery and blood donation, previous stomach or small bowel surgery, those who took treatment for H. pylori within the last three month, and pregnant women excluded. The patients were excluded, due to any of the exclusion criteria, from the study following critical review of their medical charts.

Data collection and laboratory methods

General characteristics of the study participants

A structured questionnaire was used to collect data on demographic (sex, age, monthly income, marital status, educational status), behavioral (smoking, alcohol intake, dietary habit) and physical (body mass index) characteristics of the study participants. BMI ≤ 18.5 kg/m2 was classified as underweight; BMI = 18.6–24.9 kg/m2 as normal weight; BMI = 25-29.9 kg/m2 as overweight; and BMI ≥ 30 kg/m2 as obese [25].

Sample collection and analysis

About 3 ml of venous blood was collected and examined for hematological parameters using Sysmex K-21 hematology analyzer. Approximately three gram of stool sample was collected in a clean screw cupped plastic container and checked for the presence of H. pylori antigen using H. pylori Rapid Test Strip (Creative Diagnostics.). Portion of the stool sample was used to assess the presence of intestinal helminthes using formol ether concentration technique as per a standard procedure [26].

Data analysis and interpretation

Data were entered and analyzed using SPSS version 16.0. Continuous variables were summarized using means (±SD) and categorical variables were summarized in frequencies (percentages). Association between the prevalence of anemia and H.pylori infection was assessed by χ2 tests. Anemia was defined according to the WHO definition as a hemoglobin concentration of < 12 g/dL in women, < 13 g/dL in men [27]. The difference in the mean values of RBC parameters between H.pylori positive and negative individuals was explored using independent sample T-test. Logistic regression was used to determine the effect of independent variables on the prevalence of H.pylori infection. In all case a 95% confidence interval was used and P-values less than 0.05 were considered as statistically significant.

Ethical consideration

The study was commenced after ethically approved by the ethical review committee of the School of Biomedical and Laboratory Science, University of Gondar. Permission to conduct the study was also obtained from the hospital administration. Written informed consent was obtained from each study participant and the results were kept confidential. Any result that was necessary for the patient was communicated with the physician for appropriate management.

Results

Sociodemographic, behavioral and physical characteristics of the study participants

A total of 401 adult dyspeptic patients (148 males and 253 females) with a mean (±SD) age of 37.3 (±13.7) years participated in this study. Majority of them were rural residents (70%), married (72.8%), and illiterate (56.9%). The mean (±SD) body mass index of the study population was 20.4 (±2.3) kg/m2. During the time of data collection about 4.5% and 10.7% of the study participants had a habit of cigarette smoking and drinking alcohol respectively. An assessment on the food habits of the study participants revealed that 8.7%, 63.8% and 33.4% had a habit of eating meat, vegetables and eggs 1-3 days/week respectively. Intestinal parasites were identified in 30.7% of the study participants (Table 1).
Table 1

Sociodemographic, behavioral and physical characteristics of the study participants

Characteristics

Frequency (%)

Sex

 

Female

253(63%)

Male

148(37%)

Age

 

18-28

130(32.4%)

29-38

93(23.2)

39-48

79(19.7)

49-58

66(16.5)

59-68

33(8.2)

Residence

 

Urban

120(30)

Rural

281(70)

Family income/month ETB

 

<776

271(67.6%)

≥776

130(32.4%)

Marital status

 

Married

292(72.8)

Single

72(18)

Widowed/divorced

37(9.2)

Educational status

 

Never attend school

228(56.9)

Primary school

92(22.9)

Secondary school and above

81(20.2)

BMI (kg/m2)

 

Undernourished

75(18.7)

Normal

315(78.6)

Overweight

11(2.7)

No of people in household

 

<5

298(74.3)

>6

103(25.7)

Cigarette smoking

 

Yes

18(4.5)

No

383(95.5)

Alcohol drink

 

Yes

43(10.7)

No

358(89.3)

Meat consumption per week

 

Not at all

366(91.3)

>1-3

35(8.7)

Egg consumption per week

 

Not at all

267(66.6

>1-3

134(33.4)

Vegetable consumption/week

 

Not at all

20(5)

1-3

256(63.8)

>4

125(31.2)

Intestinal parasite

 

Negative

278(69.3)

Positive

123(30.7)

Prevalence of H.pyloriinfection and associated risk factors

The overall prevalence of H. pylori infection was 52.4% (n = 210); 66.7% (n = 140) in females and 33.3% (n = 70) in males. The relative frequency of the infection was higher in the age group 39-48 (50.6%) and among urban dwellers (54.4%). Among the different characteristics of the study participants’; age, presence of intestinal parasites, smoking habit, alcohol drinking habit and BMI showed statistically significant association with H.pylori infection (Table 2).
Table 2

Bivariate and multivariate analysis of patient characteristics with H. pylori infection

Risk factors

H.pylori status

COR (95%CI)

P-value

AOR(95%CI)

P-value

 

+ve

-ve

    

Age category

      

18-28

47

83

1

 

1

 

29-38

44

49

1.58(0.92-2.72)

.095

1.37(0.77-2.45)

.277

39-48

40

39

1.81(1.03-3.20)

.040

1.74(0.95-3.17)

.070

49-58

49

17

5.09(2.64-9.82)

.000

5.18(2.58-10.42)

.000

59-68

30

3

17.66(5.11-60.2)

.000

17.63(4.95-62.7)

.000

Intestinal helminthes

      

Negative

132

146

1

 

1

 

Positive

78

45

1.92(1.24-2.96)

.003

1.9(1.17-3.07)

.009

Smoking

      

Yes

16

2

7.89(1.77-34.36)

.007

8.36(1.68-41.64)

 

No

194

189

1

 

1

 

Alcohol drink

      

Yes

18

25

0.62(0.33-1.18)

.15

0.37(0.17-0.82)

.014

No

192

166

1

 

1

 

BMI category

     

.

Undernourished

53

22

2.00(0.55-7.27)

0.28

3.16(0.75-13.39)

.119

Normal

151

164

0.77(0.23-2.56)

0.67

1.10(0.28-4.29)

.889

Overweight

6

5

1

 

1

 

Anemia

      

Anemic

50

58

0.637(0.38-1.04)

0.072

1.58(0.96-2.61)

0.072

Non anemic

160

133

1

 

1

 

Prevalence of anemia and its association with H.pyloriinfection

Prevalence of anemia among dyspeptic patient was 26.9% (n = 108); 64.8% in females and 35.2% in males. The mean (±SD) hemoglobin concentration was 13.2(±1.4) g/dl and 14.1(±1.5) g/dl in females and males respectively. The prevalence of anemia among H.pylori infected patients was 30.9% and 22.5% among uninfected patients. The difference in the prevalence of anemia between H.pylori infected and uninfected patients was statistically significant (χ2 = 26.8; P < 0.001) (Table 3). The mean (SD) of other parameters related to red blood cell were also compared between H.pylori infected and uninfected patients. Accordingly statistically significant differences were observed in HGB, MCV, MCH, MCHC, HCT and number of RBC (Table 4).
Table 3

Association between H.pylori sero-status and anemia prevalence among dyspeptic patients

 

H.pylori sero-positive

H.pylori sero-negative

χ 2 ( P-value )

Anemic

65 (30.95)

43 (22.5)

3.62 (0.05)

Non anemic

145 (69.01)

148 (77.5)

 
Table 4

Association between RBC indices with H.pylori infection

Parameter

Mean (SD)

P-value (95% CI)

 

H.pylori positive

H.pyori negative

 

HGB

13.3(1.3)

13.8 (1.6)

0.001(0.19, 0.77)

MCV(fl)

87.5(7.2)

88.9(7.3)

0.058 (-0.048, 2.79)

MCH

27.85(2.54)

28.65(2.78)

0.003 (0.28, 1.33)

MCHC (ρg)

31.35(2.03)

32(2.33)

0.002 (0.26, 1.12)

RBCX106/μl

4.63(0.59)

4.8(0.72)

0.01 (0.04, 0.29)

HCT (%)

41.9(5.3)

43.3(5.9)

0.009 (0.38, 2.58)

HGB = hemoglobin; MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; MCHC = mean corpuscular hemoglobin concentration; RBC = red blood cell; HCT = hematocrit.

Discussion

In this study, the prevalence of H. pylori infection among patients with dyspeptic symptoms was 52.37%. This prevalence is relatively lower than other reports conducted in different parts of African and Asia continent, which reported a prevalence ranging from 67% up to 86.8% [28]-[31]. The prevalence of H pylori varies greatly among countries and among population groups within the same country [2]. However, our finding is relatively similar with previous reports made in Ethiopia 53% [24] and Kuwait 49.7% [32]. Lack of clear cut definition of dyspepsia, H. pylori diagnostic method, sample size, social and economic factors could be some of the possible reasons for these variations.

The results of the current study also showed slight difference in prevalence of H. pylori infection between females and males (55.3% vs 47.3% respectively), but the difference was not statistically significant (P = 0.12). This finding goes in contrary to previous reports that indicated females were at significant risk to have for H. pylori infection (24, 32,33). However, our findings agree with other studies that showed the rate of H. pylori infection is independent of gender [31],[24],[30].

We found correlation between age and H. pylori infection being the prevalence was higher in older age groups (P < 0.001). This finding is in accordance with the results of former studies made in Kuwait [32] South Africa [33] and Ethiopia [30]. Moreover, study conducted in Addis Ababa, Ethiopia, showed a peak prevalence of H. pylori infection among older patients, within the age group between 54-61 years [24]. The most probable reason is that infection by H. pylori can be acquired in earlier age and persist throughout the life time of the patient and may cause disease at older age. However, there are also reports that showed higher prevalence of H. pylori infection during the younger age. For example, study conducted in Iran showed patient at younger age were more affected [31] and in Nigeria the peak prevalence of H. pylori infection was found among patients within the age group between 20-39 years old [29].

The current study result also showed a significant negative association betteween alcohol consumption and H. pylori infection (AOR 0.37; 95%; CI 0.17-0.82, P = 0.014). This result contradicts with previous report from Gondar, Ethiopia [30] and South Africa [33] that showed a positive association between H. pylori infection and alcohol consumption. In those studies it was reported that alcohol consumption could be a risk factor for H. pylori infection. Nevertheless, there are also reports that documented a non statistical risk reduction of H. pylori infection upon alcohol consumption [34]. Besides, the type and amount of alcohol had also an effect on the association. However, basic microbiology tells us that alcohol is known to have direct antimicrobial effects. Therefore, the lower prevalence of H. pylori infection among patients that consumed alcohol compared with the non-alcoholics attracted us to support the hypothesis that alcohol intake may have preventive effect for H. pylori infection.

In this study cigarette smoking was significantly associated with H. pylori infection (P = 0.01). Unlike other studies that reported no significant association with current smoking or any other measure of using tobacco [34]. Others proposed that smoking appears to affect treatment success [35]. These contradictory results may be due to uncontrolled confounding factors such as social class or differential antibiotic use.

Intestinal parasitic infection in this study was significantly associated with H. pylori infection (p = 0.009). This is different from a finding from Australia [36]. Intestinal parasitic infections and elevated IgE levels were associated with a reduced H. pylori prevalence in adults, living in Mexico, suggesting that intestinal parasites could affect persistence of H. pylori [37]. The presence of association in our study may be due to poor hygienic status that favors high rate of parasitic infection and similar route of transmission shared by H.pylori. But the real mechanism of interaction needs to be investigated with cohort studies.

There are quite a number of studies in the literature demonstrated the relationship between H. pylori infection and anemia. In the current study, the prevalence of anemia among H. pylori positive patients (n = 65, 30.95%) was significantly higher (P = 0.05) than H .pylori negative patients (n = 43; 22.5%). But other studies from Latin American countries showed no association [38] while a study from Haiti showed an inverse association [39]. The association observed in our study was also reflected on other RBC parameters as determined using t-test. We found that H. pylori stool antigen positive patients have significantly lower hemoglobin and hematocrit levels than H. pylori negative patients (13.3 g/dl versus 13.8 g/dl, P = 0.001) and (41.9% versus 43.3%, P = 0.009) respectively. Similar observation was reported from Turkish among teenager [40]. However, findings are not in agreement with the reports made by Fraser et al [41] and Kermati et al [42] where no association between H. pylori infection and Hgb/HCT levels was reported. Moreover, there was statistically significant difference in MCHC (P = 0.002) and MCH (P = 0.003) values between H. pylori stool antigen positive and negative dyspeptic patients, indicating the impact of H. pylori infection on hematological parameters.

Limitations of the study

This study was conducted on dyspeptic patients who have had many underline disease conditions as a confounding factors that could not fully controlled so that it might have impact on the outcome of the statistical correlations between H. pylori infection, anemia and other variables of interest. The cross sectional nature of the study was also another limitation to show cause and effect relationship between the variables.

Conclusion

This study indicated that the prevalence of H. pylori infection was high among dyspeptic patients in the study area. The rate of H. pylori infection was also increasing in advancing age showing that age is one of the risk factors in acquiring the infection. Moreover, cigarette smoking, and intestinal helmintic infection were identified as risk factors for H. pylori infection too. Alcohol consumption habit in our study was negatively associated with H. pylori infection. Mean hematological parameters and RBC were significantly reduced among H. pylori positive patients compared. This study indicated the need for further large scale study to determine the possible risk factors for such high rate of infection. Moreover cohort type studies are recommended to formulate a cause and effect relationship between the risk factors and H.pylori sero-positivity.

Declarations

Acknowledgment

We would like to acknowledge all study participants who were volunteers to give samples and respond to questionnaires. Our special thanks go to Butajira hospital administration for their unreserved support during the data collection.

Authors’ Affiliations

(1)
Butajira Zonal Hospital, Southern Nations, Nationalities and Peoples Region
(2)
Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, University of Gondar
(3)
Deapartment of Medical MIcrobiology, School of Biomedical and Laboratory Sciences, University of Gondar

References

  1. Hunt RH, Xiao SD, Megraud F, Leon-Barua R, Bazzoli F, van der Merwe S, Vaz Coelho LG, Fock M, Fedail S, Cohen H, Malfertheiner P, Vakil N, Hamid S, Gohl KL, Wong BC, Krabshuis J, Le Mair A: World Gasteroenterology Organization Global Guide line: Helicobacter pylori in Developing Countries. World Gasteroenerology Organization, 2010. , [http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/11_helicobacter_pylori_developing_countries_en.pdf]
  2. Suerbaum S, Michetti P: Helicobacter pylori infection. N Engl J Med. 2002, 347: 1175-1186. 10.1056/NEJMra020542.View ArticlePubMedGoogle Scholar
  3. Torres J, Perez-Perez G, Goodman KJ, Atherton JC, Gold BD, Harris PR, La Garza AM, Guarner J, Muñoz O: A comprehensive review of the natural history of Helicobacter pylori infection in children. Arch Med Res. 2000, 31: 431-469. 10.1016/S0188-4409(00)00099-0.View ArticlePubMedGoogle Scholar
  4. Cover TL, Blaser MJ: Helicobacter pylori in health and disease. Gastroenterology. 2009, 136: 1863-1873. 10.1053/j.gastro.2009.01.073.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Egan BJ, O’Connor HJ, Morain CAO: What is new in the management of Helicobacter pylori?. Ir J Med Sci. 2008, 177: 185-188. 10.1007/s11845-008-0173-8.View ArticlePubMedGoogle Scholar
  6. Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ: Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007, 56: 772-781. 10.1136/gut.2006.101634.View ArticlePubMedGoogle Scholar
  7. Ford AC, Axon ATR: Epidemiology of Helicobacter pylori infection and Public Health Implications. Helicobacter. 2010, 15: 1-6. 10.1111/j.1523-5378.2010.00779.x.View ArticlePubMedGoogle Scholar
  8. Qu XH, Huang XL, Xiong P, Zhu CY, Huang YL, Lu LG, Sun X, Rong L, Zhong L, Sun DY, Lin H, Cai MC, Chen ZW, Hu B, Wu LM, Jiang YB, Yan WL: Does Helicobacter pylori infection play a role in iron deficiency anemia? A metaanalysis. World J Gastroenterol. 2010, 16: 886-896.PubMedPubMed CentralGoogle Scholar
  9. Muhsen K, Cohen D: Helicobacter pylori infection and iron stores: a systematic review and meta-analysis. Helicobacter. 2008, 13: 323-340. 10.1111/j.1523-5378.2008.00617.x.View ArticlePubMedGoogle Scholar
  10. Sarari AS, Farraj MA, Hamoudi W, Essawi TA: Helicobacter pylori, a causative agent of vitamin B12 deficiency. J Infect Dev Countries. 2008, 2: 346-349.Google Scholar
  11. Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, Provan D, Newland A, Amadori S, Bussel JB: Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2009, 113: 1231-1240. 10.1182/blood-2008-07-167155.View ArticlePubMedGoogle Scholar
  12. Baggett HC, Parkinson AJ, Muth PT, Gold BD, Gessner BD: Endemic iron deficiency associated with helicobacter pylori infection among school-aged children in Alaska. Pediatrics. 2006, 117: 396-404. 10.1542/peds.2005-1129.View ArticleGoogle Scholar
  13. Ashorn M, Ruuska T, Makipenaa A: Helicobacter pylori infection and iron deficiency anemia in children. Scand J Gastroenterol. 2001, 36: 701-705. 10.1080/003655201300191950.View ArticlePubMedGoogle Scholar
  14. Valiyaveettil AN, Hamide A, Bobby Z, Krishnan R: Effect of anti-Helicobacter pylori therapy on outcome of iron-deficiency anemia: a randomized, controlled study. Indian J Gastroenterol. 2005, 24: 155-157.PubMedGoogle Scholar
  15. Malik R, Guleria K, Kaur I, Sikka M, Radhakrishnan G: Effect of Helicobacter pylori eradication therapy in iron deficiency anaemia of pregnancy – A pilot study. Indian J Med Res. 2011, 134: 224-231.PubMedPubMed CentralGoogle Scholar
  16. Harris PR, Serrano CA, Villagrán A, Walker MM, Thomson M, Duarte I, Windle HJ, Crabtree JE: Helicobacter pylori-associated hypochlorhydria in children, and development of iron deficiency. J Clin Pathol. 2013, 66: 343-347. 10.1136/jclinpath-2012-201243.View ArticlePubMedGoogle Scholar
  17. Shaw JG, Friedman JF: Iron deficiency anemia: focus on infectious diseases in lesser developed countries. Anemia 2011:1–10. , [http://www.hindawi.com/journals/anemia/2011/260380/]
  18. Annibale B, Capurso G, Lahner E, Passi S, Ricci R, Maggio F, Delle FG: Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut. 2003, 52: 496-501. 10.1136/gut.52.4.496.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Conrad ME, Umbreit JN: Iron absorption and transport-an update. Am J Hematol. 2000, 64: 287-298. 10.1002/1096-8652(200008)64:4<287::AID-AJH9>3.0.CO;2-L.View ArticlePubMedGoogle Scholar
  20. Lacy BE, Rosemore J: Helicobacter pylori: ulcers and more: the beginning of an Era;symposium. J Nutr. 2001, 131: 2789-2793.Google Scholar
  21. Doig P, Austin JW, Trust TJ: The Helicobacter pylori 19.6-kilodalton protein is an iron-containing protein resembling ferritin. J Bacteriol. 1993, 61: 2694-2697.Google Scholar
  22. Seo JK, Ko JS, Choi KD: Serum ferritin and Helicobacter pylori infection in children: a sero-epidemiologic study in Korea. J Gastroenterol Hepatol. 2002, 17: 754-757. 10.1046/j.1440-1746.2002.02797.x.View ArticlePubMedGoogle Scholar
  23. Kandulski A, Venerito M, Malfertheiner S: Therapeutic strategies for the treatment of dyspepsia. Expert Opin Pharmaco Ther. 2010, 11: 2517-2525. 10.1517/14656566.2010.501794.View ArticleGoogle Scholar
  24. Taddesse G, Habteselassie A, Desta K, Esayas S, Bane A: Association of dyspepsia symptoms and Helicobacter pylori infections in private higher clinic, Addis Ababa, Ethiopia. Ethiop Med J. 2011, 49: 109-116.PubMedGoogle Scholar
  25. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Curtin LR, Roche AF, Johnson CL: CDC growth charts for the United States: methods and development. Vital Health Stat. 2002, 11: 1-190.Google Scholar
  26. Cheesbrough M: District Laboratory Practice in Tropical Countries Part I. 2006, Cambrige University Press, New York, 2View ArticleGoogle Scholar
  27. Iron Deficiency Anaemia: As -sessment, Prevention and Control. A Guide for Programme Managers. 2001, WHO, Geneva, SwitzerlandGoogle Scholar
  28. Hashemi MR, Rahnavardi M, Bikdeli B, Zahedani MD: H. pylori infection among 1000 southern Iranian dyspeptic Patients. World J Gastroenterol. 2006, 12: 5479-5482.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Mustapha S, Pindiga U, Yusuph H, Goni B, Jibrin Y: Helicobacter pylori infection among dyspeptic patients at a tertiary hospital in Northern Nigeria. Int J Infect Dis. 2011, 9: 42-48.Google Scholar
  30. Moges F, Kassu A, Mengistu G, Adugna S, Andualem B, Nishikawa T, Ota F: Seroprevalence of Helicobacter pylori in dyspeptic patients and its relationship with HIV infection, ABO blood groups and life style in a university hospital, Northwest Ethiopia. World J Gastroenterol. 2006, 12: 1957-1961.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Shokrzadeh L, Baghaei K, Yamaoka Y, Shiota S, Mirsattari D, Porhoseingholi A, Zali MR: Prevalence of Helicobacter pylori infection in dyspeptic patients in Iran. Gastroenterol Insights. 2012, 4: 24-27. 10.4081/gi.2012.e8.View ArticleGoogle Scholar
  32. Alazmi WM, Siddique I, Alateeqi N, Al-Nakib B: Prevalence of Helicobacter pylori infection among new outpatients with dyspepsia in Kuwait. BMC Gastroenterol. 2010, 10: 1-4. 10.1186/1471-230X-10-14.View ArticleGoogle Scholar
  33. Tanih NF, Okeleye BI, Ndip LM, Clarke AM, Naidoo N, Mkwetshana N, Green E, Ndip RN: Helicobacter pylori prevalence in dyspeptic patients in the Eastern Cape province – race and disease status. S Afr Med J. 2010, 100: 734-737.View ArticlePubMedGoogle Scholar
  34. Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N: Smoking behavior and risk of helicobacter pylori infection, gastric atrophy and gastric cancer in Japanese. Asian Pac J Cancer Prev. 2010, 11: 313-317.PubMedGoogle Scholar
  35. Suzuki T, Matsuo K, Ito H, Sawaki A, Hirose K, Wakai K, Sato S, Nakamura T, Yamao K, Ueda R, Tajima K: Smoking increases the treatment failure for helicobacter pylori eradication. Am J Med. 2006, 119: 217-224. 10.1016/j.amjmed.2005.10.003.View ArticlePubMedGoogle Scholar
  36. Cherian S, Forbes D, Sanfilippo F, Cook A, Burgner D: Helicobacter pylori, helminth infections and growth: a cross-sectional study in a high prevalence population. Acta Paediatr. 2009, 95: 860-864. 10.1111/j.1651-2227.2009.01221.x.View ArticleGoogle Scholar
  37. Torres J, Perez GP, Ximenez C, Muñoz L, Camorlinga-Ponce M, Ramos F, Gomez A, Muñoz O: The association of intestinal parasitosis and H. Pylori infection in children and adults from a Mexican community with high prevalence of parasitosis. Helicobacter. 2003, 8: 179-185. 10.1046/j.1523-5378.2003.00142.x.View ArticlePubMedGoogle Scholar
  38. Santos IS, Boccio J, Davidsson L, Hernandez-Triana M, Huanca-Sardinas E, Janjetic M, Moya-Camarena SY, Paez-Valery MC, Ruiz-Alvarez V, Valencia ME, Valle NCJ, Vargas-Pinto G, Solano L, Thomas J: Helicobacter pylori is not associated with anaemia in Latin America: results from Argentina, Brazil, Bolivia, Cuba, Mexico and Venezuela. Public Health Nutr. 2009, 12: 1862-1870. 10.1017/S1368980009004789.View ArticlePubMedGoogle Scholar
  39. Shak JR, Sodikoff JB, Speckman RA, Rollin FG, Chery MP, Cole CR, Suchdev PS: Anemia and Helicobacter pylori seroreactivity in a rural Haitian population. Am J Trop Med Hyg. 2011, 85: 913-918. 10.4269/ajtmh.2011.11-0101.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Süoglu OD, Gökçe S, Saglam AT, Sökücü S, Saner G: Association of Helicobacter pylori infection with gastroduodenal disease, epidemiologic factors and iron-deficiency anemia in Turkish children undergoing endoscopy, and impact on growth. Pediatr Int. 2007, 49: 858-863. 10.1111/j.1442-200X.2007.02444.x.View ArticlePubMedGoogle Scholar
  41. Fraser AG, Scragg R, Schaaf D, Metcalf P, Grant CC: Helicobacter pylori infection and iron deficiency in teenage females in New Zealand. N Z Med J. 2010, 123: 38-45.PubMedGoogle Scholar
  42. Kermati MR, Siadat Z, Mahmoudi M: The correlation between H pylori infection with serum ferritin concentration and iron deficiency anemia. Int J Hematol Oncol. 2007, 17: 16-20.Google Scholar

Copyright

© Kibru et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement